Gem/Cis gets nab-paclitaxel By Steve|2024-10-11T16:11:47+13:00July 25th, 2019|Categories: All, Z-Legacy|Tags: Chemotherapy, Trial News| Read More 0
Treatment options improving for Cholangiocarcinoma By Steve|2024-10-11T16:12:25+13:00October 15th, 2018|Categories: All, Immunotherapy, Z-Legacy|Tags: ABC-02, ARID1A, BAP1, BAY1436032, BRAF, BRCA1/2, Chemotherapy, Cyramza, dmmr, EGFR, epigenetic, FGFR2, Gem/Cis, GENOME, HER2 amplification, IDH1, IDH1/2, immunotherapy, Kelly, KEYNOTE-158, Keytruda, Lynparza, MEK, MET, MMR, olaparib, Oncologists, ramucirumab, TAS-120, TP53, treatment, TreeTopp, VEGFR, VEGFR2| Read More 0
Chemotherapy and Cholangiocarcinoma By Steve|2024-10-11T16:12:26+13:00October 1st, 2018|Categories: All, Chemotherapy, Z-Legacy|Tags: Chemotherapy, videos-chemotherapy| Read More 0
Cycling in the Chemo By Steve|2024-10-11T16:13:35+13:00July 18th, 2018|Categories: All, Chemotherapy, Z-Legacy|Tags: Australia, Chemotherapy, Exercise| Read More 0
Capecitabine Improves Survival of Patients with Rare Cancer by Almost a Quarter By Steve|2024-10-11T16:13:36+13:00April 23rd, 2018|Categories: All, Chemotherapy, Z-Legacy|Tags: capecitabine, Chemotherapy| Read More 0